CD39 Antibody (YA4685)

Cat. No.: HY-P84993: Data Sheet User Guide for Antibodies
FAQs
Technical Support

CD39 Antibody (YA4685) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to CD39.

For research use only. We do not sell to patients.

Size		Stock
50 μL		Get quote
100 μL		Get quote

* Please select Quantity before adding items.

WB: Western Blot;
IHC-P: Immunohistochemistry-Paraffin;
IHC-F: Immunohistochemistry-Frozen;
ICC/IF: Immunocytochemistry/Immunofluorescence;
IF-Tissue: Immunofluorescence-Tissue;
mIHC: Multiplex Immunohistochemical;
IP: Immunoprecipitation;
ChIP: Chromatin Immunoprecipitation;
FC: Flow Cytometry;
ELISA: Enzyme Linked Immunosorbent Assay

Product Detail
Background
Documentation

Description

CD39 Antibody (YA4685) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to CD39.

Host

Mouse

Clonality

Monoclonal

Species Reactivity

Human

SwissProt ID

P49961

Gene ID

953 [NCBI]

Immunogen

Purified recombinant Human CD39

Application &
Dilution Ratio

Application	Dilution Ratio
ELISA ELISA: Enzyme Linked Immunosorbent Assay	1:5000-100000

Purity	affinity purified.	Conjugation	Non-conjugated
Modification	Unmodified

Appearance

Liquid

Formulation

Supplied in Phosphate-buffered solution.

Storage & Stability

Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

Shipping

Shipping with blue ice.

Background

Function：Catalyzes the hydrolysis of both di- and triphosphate nucleotides (NDPs and NTPs) and hydrolyze NTPs to nucleotide monophosphates (NMPs) in two distinct successive phosphate-releasing steps, with NDPs as intermediates and participates in the regulation of extracellular levels of nucleotides (Probable) (PubMed:8529670, PubMed:8626624, PubMed:8955160, PubMed:8996251). By hydrolyzing proinflammatory ATP and platelet-activating ADP to AMP, it blocks platelet aggregation and supports blood flow (PubMed:8955160, PubMed:8996251)

Subcellular Localization：Membrane; Multi-pass membrane protein; Membrane, caveola

Expression：
Tissue_specificity:It is primarily expressed on activated lymphocytes (PubMed:7930580) . It is also expressed in endothelial tissues (PubMed:8955160) . It is highly expressed in the placenta, lungs, skeletal muscle, and kidneys (PubMed:8955160) .

Isoforms & Post-Translational Modification：P49961 has 6 isomers: P49961-1: 57965 Da (predicted); P49961-2: 58706 Da (predicted); P49961-3: 34175 Da (predicted); P49961-4: 42731 Da (predicted); P49961-5: 46180 Da (predicted); P49961-6: 59325 Da (predicted).
N-glycosylated;The N-terminus is blocked;Palmitoylated on Cys-13; which is required for caveola targeting

Subunit：Homodimer; disulfide-linked

Synonyms

ENTPD1; CD39; Ectonucleoside triphosphate diphosphohydrolase 1; NTPDase 1; Ecto-ATP diphosphohydrolase 1; Ecto-ATPDase 1; Ecto-ATPase 1; Ecto-apyrase; Lymphoid cell activation antigen; CD39; CD39 nanobody;

Documentation

User Guide for Antibodies (1077 KB)